Kratom Research Institute

News · 2026-08-25

Botanic Tonics Commends DEA Action Against Synthetic Kratom Derivatives, Says feel free CLASSIC Unaffected

Source: Rutland Herald / EZ Newswire

Why it matters

A major kratom-adjacent supplement brand is publicly welcoming federal enforcement against synthetic compounds, signaling a fracture in the broader 'kratom' market between companies selling natural botanical products and those that have been selling lab-synthesized opioids under a kratom label.

The big picture

Botanic Tonics, maker of the feel free CLASSIC supplement (natural kratom leaf plus kava root), has long drawn a marketing distinction between its botanical formulation and what it characterizes as rogue synthetic products. The DEA's August 26 action validates that distinction at the federal regulatory level. The company's statement also cites the DOJ press release directly, reinforcing that MGPI has not been established as a naturally occurring kratom alkaloid. The broader industry division between natural kratom vendors and synthetic product sellers is now reflected in federal law.

Key findings

What they say

"Consumers deserve products that are exactly what they say they are," said Botanic Tonics. "What the DEA acted on this week were lab-made opioids dressed up in kratom packaging to fool people looking for a natural alternative. That's a different category of product entirely, and drawing that distinction clearly has been a priority for us long before this ruling."

Bottom line

With federal law now drawing a chemical line between natural kratom and synthetic derivatives, brands like Botanic Tonics that built their products around botanical leaf stand on the legally clearer side of the enforcement boundary.